Heena Gandevia

Heena Gandevia currently serves as a Senior Research Associate at Intellia Therapeutics, Inc. since April 2023, following a tenure as a Research Associate at Foghorn Therapeutics, Inc. from November 2021 to April 2023. Prior to this, Heena Gandevia conducted graduate studies at Boston University, earning a Master's degree in Cell and Molecular Biology while researching cell death and corpse clearance in the McCall lab using Drosophila melanogaster as a model organism. Heena Gandevia also gained research experience as a Research Assistant at the University of Massachusetts Boston, focusing on the sex determination of zebrafish and the gene deadend. Heena Gandevia holds a Bachelor of Science degree in Biology from UMass Boston, completed in June 2017.